BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wen L, Weng S, Yan C, Ye R, Zhu Y, Zhou L, Gao L, Li Y. A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation. Front Oncol 2021;11:657039. [PMID: 34026632 DOI: 10.3389/fonc.2021.657039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Yan L, Li X, Yuan Y. CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker. Clinics 2022;77:100029. [DOI: 10.1016/j.clinsp.2022.100029] [Reference Citation Analysis]
2 Demircioğlu A. Measuring the bias of incorrect application of feature selection when using cross-validation in radiomics. Insights Imaging 2021;12:172. [PMID: 34817740 DOI: 10.1186/s13244-021-01115-1] [Reference Citation Analysis]
3 Gong XQ, Tao YY, Wu YK, Liu N, Yu X, Wang R, Zheng J, Liu N, Huang XH, Li JD, Yang G, Wei XQ, Yang L, Zhang XM. Progress of MRI Radiomics in Hepatocellular Carcinoma. Front Oncol 2021;11:698373. [PMID: 34616673 DOI: 10.3389/fonc.2021.698373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gao W, Wang W, Song D, Yang C, Zhu K, Zeng M, Rao SX, Wang M. A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma. Radiol Med 2022. [PMID: 35129757 DOI: 10.1007/s11547-021-01445-6] [Reference Citation Analysis]